PREPRINT (not peer reviewed)

Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: PsyArXiv
Date: 2021-05-19
Source: PsyArXiv
DOI: 10.1037/pne0000290
PubMed: Unavailable

Authors

Evan Lewis-Healey Ruben Eero Laukkonen Michiel van Elk

Watch author

Derived topics and classifications

psilocybin Depression Mechanism of Action Clinical Trial Drug Interactions Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network2021-05-19

Related papers

Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04 Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexiaPsychedelics. · 2026-02-03 Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?Psychedelics. · 2025-09-02 Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27 Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapyPsychedelics. · 2025-10-21 Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disordersPsychedelics. · 2025-06-10 Michael A. Wheeler: Psychedelics and neuroimmune circuits-what a strange trip, indeedPsychedelics. · 2025-05-06